Skip to content
Review Open access

Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems

Sep 2026 · Pharmaceutics · Vol 18, pp. 1124 · 0 citations · 70 references
Medicine

TL;DR

An integrated roadmap combining molecular engineering, disease-specific delivery, disease-specific delivery, pharmacokinetic/pharmacodynamic biomarkers, manufacturability assessment, and repeated-dose safety evaluation may help transform Klotho from a promising anti-aging molecule into a clinically viable biologic platform.

Abstract

Klotho is a longevity-associated and tissue-protective protein involved in mineral metabolism, oxidative stress, inflammation, fibrosis, cellular senescence, and neurovascular homeostasis. However, nearly three decades after its discovery, no Klotho-based therapy has been approved, highlighting a translational gap that extends beyond biological validation. This review reframes Klotho translation as a pharmaceutical sciences challenge, focusing on how to convert Klotho into a druggable, manufacturable, deliverable, and clinically controllable therapeutic product. We summarize the isoform-specific properties of membrane-bound α-Klotho, soluble α-Klotho, and β-Klotho that are relevant to product design, and review the current clinical and preclinical landscape dominated by gene-, mRNA-, and antibody-based approaches. We further distinguish confirmed developability barriers, including renal handling and limited systemic persistence, from plausible risks common to macromolecular biologics, such as aggregation, chemical degradation, immunogenicity, and poor tissue penetration. Finally, we evaluate emerging delivery and formulation strategies, including viral and non-viral gene delivery, extracellular vesicles, hydrogels, ultrasound-targeted microbubbles, osmotic pumps, and long-acting protein engineering. An integrated roadmap combining molecular engineering, disease-specific delivery, pharmacokinetic/pharmacodynamic biomarkers, manufacturability assessment, and repeated-dose safety evaluation may help transform Klotho from a promising anti-aging molecule into a clinically viable biologic platform.

Read PDF

Similar papers

Review Sep 2026

From Laboratory to Clinic: Translational Challenges, Lessons, and Future Strategies for microRNA Delivery Systems.

A Four-Pillar Framework integrating Delivery Systems, Immune Safety, CMC and Manufacturing Readiness, and biomarker-guided Clinical Design is proposed to support coordinated optimization across biological, pharmaceutical, and clinical dimensions rather than isolated improvement of individual delivery parameters.

Qian-Qian Liu, Li-Wei Jia, Xin Meng et al. · 0 citations
Review Oct 2026

Nanoparticle-based senolytic and senomorphic therapies for healthy aging: design principles, translational evidence, and challenges.

Cellular senescence contributes to age-associated tissue dysfunction through persistent growth arrest, metabolic remodeling, and altered communication with immune and stromal cells. Senolytic therapies preferentially eliminate susceptible senescent cells, while senomorphic therapies modulate harmful senescence-associat...

Jia-Bin Huang, Li-Chen Ji, Hui-Hui Jin et al. · 0 citations
Review Oct 2026

From biomarkers to therapeutic targets: Biomaterial-mediated cfDNA scavenging in inflammation.

Cell-free DNA (cfDNA) displays disease-dependent changes in abundance, fragmentation, composition, and tissue origin. Beyond serving as a noninvasive biomarker, persistent cfDNA can act as a damage-associated molecular pattern, activating TLR9, cGAS-STING, inflammasome signaling, and thromboinflammation. This review sy...

Shi-Bo Liu, Xu Cheng, Lin-Yi Liu et al. · 0 citations
Review Sep 2026

Convergence of Natural Products and Nanomedicine in Diabetes Care: Therapeutic Innovations and Translational Challenges

The convergence of natural products and nanomedicine is reshaping diabetes care by enabling multi-target therapeutics with improved pharmacokinetics, tissue distribution, and dosing consistency. Natural antidiabetic compounds polyphenols, alkaloids, terpenoids, and saponins- exert complementary actions on insulin sensi...

Mukisa Ian Mugaiga · 0 citations
Review Open access Aug 2026

Extracellular Vesicles and Plant-Derived Vesicles in Cancer: From Mechanisms to Clinical Translation

The growing applicability of EVs as next-generation platforms for precision medicine, targeted drug delivery, and regenerative therapies is summarized while identifying the major obstacles that must be addressed to facilitate their successful clinical translation.

Shery Jacob, Namitha Raichel Varkey, S. Boddu et al. · 0 citations
Review Open access Oct 2026

Exosome-Based Therapies for Skin Aging: Sources, Mechanisms, and Evidence from Preclinical and Clinical Studies

Abstract Skin aging is an inevitable physiological process co-driven by endogenous genetic programs and exogenous environmental factors, characterized by the progressive deterioration of skin structure and function, which manifests as wrinkles, sagging, pigmentation, and impaired barrier function. Extracellular vesicle...

Bo-Yu Zhang, Xin-Rong Xue, Yi-Ping Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.